Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Biotechnol J ; 14(7): e1800675, 2019 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30925020

RESUMO

Biopharmaceutical manufacturing using Chinese hamster ovary (CHO) cells requires the generation of high-producing clonal cell lines. During cell line development, cell cloning using fluorescence-activated cell sorting (FACS) has the potential to combine isolation of single cells with sorting based on specific cellular attributes that correlate with productivity and/or growth, identifying cell lines with desirable phenotypes for manufacturing. This study describes the application of imaging flow cytometry (IFC) to characterize recombinant cell lines at the single-cell level to identify cell attributes predictive of productivity. IFC assays are developed to quantify the organelle content and recombinant heavy-chain (HC) and light-chain (LC) polypeptide as well as messenger RNA (mRNA) amounts in single cells. The assays are then validated against orthogonal standard flow cytometry, western blot, and quantitative reverse transcription polymerase chain reaction (qRT-PCR) methods. The authors describe how these IFC assays may be used in cell line development and show how cellular properties can be correlated with productivity at the single-cell level, allowing the isolation of such cells during the cloning process. From the analysis, HC polypeptide and mRNA are found to be predictive of productivity early in the culture; however, specific organelle content did not show any correlation with productivity.


Assuntos
Citometria de Fluxo/métodos , Espaço Intracelular/diagnóstico por imagem , Análise de Célula Única/métodos , Animais , Células CHO , Cricetinae , Cricetulus , Processamento de Imagem Assistida por Computador , RNA Mensageiro/genética , RNA Mensageiro/metabolismo
2.
Mol Psychiatry ; 23(9): 1851-1867, 2018 09.
Artigo em Inglês | MEDLINE | ID: mdl-29904150

RESUMO

Benzodiazepines facilitate the inhibitory actions of GABA by binding to γ-aminobutyric acid type A receptors (GABAARs), GABA-gated chloride/bicarbonate channels, which are the key mediators of transmission at inhibitory synapses in the brain. This activity underpins potent anxiolytic, anticonvulsant and hypnotic effects of benzodiazepines in patients. However, extended benzodiazepine treatments lead to development of tolerance, a process which, despite its important therapeutic implications, remains poorly characterised. Here we report that prolonged exposure to diazepam, the most widely used benzodiazepine in clinic, leads to a gradual disruption of neuronal inhibitory GABAergic synapses. The loss of synapses and the preceding, time- and dose-dependent decrease in surface levels of GABAARs, mediated by dynamin-dependent internalisation, were blocked by Ro 15-1788, a competitive benzodiazepine antagonist, and bicuculline, a competitive GABA antagonist, indicating that prolonged enhancement of GABAAR activity by diazepam is integral to the underlying molecular mechanism. Characterisation of this mechanism has revealed a metabotropic-type signalling downstream of GABAARs, involving mobilisation of Ca2+ from the intracellular stores and activation of the Ca2+/calmodulin-dependent phosphatase calcineurin, which, in turn, dephosphorylates GABAARs and promotes their endocytosis, leading to disassembly of inhibitory synapses. Furthermore, functional coupling between GABAARs and Ca2+ stores was sensitive to phospholipase C (PLC) inhibition by U73122, and regulated by PLCδ, a PLC isoform found in direct association with GABAARs. Thus, a PLCδ/Ca2+/calcineurin signalling cascade converts the initial enhancement of GABAARs by benzodiazepines to a long-term downregulation of GABAergic synapses, this potentially underpinning the development of pharmacological and behavioural tolerance to these widely prescribed drugs.


Assuntos
Diazepam/metabolismo , Diazepam/farmacologia , Receptores de GABA-A/metabolismo , Animais , Benzodiazepinas/farmacologia , Calcineurina/metabolismo , Tolerância a Medicamentos/genética , Tolerância a Medicamentos/fisiologia , Antagonistas GABAérgicos/farmacologia , Moduladores GABAérgicos/metabolismo , Células HEK293 , Hipocampo/metabolismo , Humanos , Masculino , Neurônios/metabolismo , Fosfoinositídeo Fosfolipase C/metabolismo , Ratos , Ratos Sprague-Dawley , Receptores de GABA/metabolismo , Transdução de Sinais , Sinapses/metabolismo , Ácido gama-Aminobutírico/metabolismo
3.
Cell Stem Cell ; 15(1): 79-91, 2014 Jul 03.
Artigo em Inglês | MEDLINE | ID: mdl-24996170

RESUMO

Defects in brain development are believed to contribute toward the onset of neuropsychiatric disorders, but identifying specific underlying mechanisms has proven difficult. Here, we took a multifaceted approach to investigate why 15q11.2 copy number variants are prominent risk factors for schizophrenia and autism. First, we show that human iPSC-derived neural progenitors carrying 15q11.2 microdeletion exhibit deficits in adherens junctions and apical polarity. This results from haploinsufficiency of CYFIP1, a gene within 15q11.2 that encodes a subunit of the WAVE complex, which regulates cytoskeletal dynamics. In developing mouse cortex, deficiency in CYFIP1 and WAVE signaling similarly affects radial glial cells, leading to their ectopic localization outside of the ventricular zone. Finally, targeted human genetic association analyses revealed an epistatic interaction between CYFIP1 and WAVE signaling mediator ACTR2 and risk for schizophrenia. Our findings provide insight into how CYFIP1 regulates neural stem cell function and may contribute to the susceptibility of neuropsychiatric disorders.


Assuntos
Junções Aderentes/genética , Transtorno Autístico/metabolismo , Células-Tronco Pluripotentes Induzidas/fisiologia , Células-Tronco Neurais/fisiologia , Esquizofrenia/metabolismo , Proteína 2 Relacionada a Actina/metabolismo , Proteínas Adaptadoras de Transdução de Sinal/genética , Junções Aderentes/patologia , Adulto , Animais , Transtorno Autístico/genética , Transtorno Autístico/patologia , Linhagem Celular , Polaridade Celular/genética , Aberrações Cromossômicas , Cromossomos Humanos Par 15/genética , Variações do Número de Cópias de DNA , Epistasia Genética , Estudos de Associação Genética , Haploinsuficiência , Humanos , Deficiência Intelectual/genética , Masculino , Camundongos , Camundongos Endogâmicos , Pessoa de Meia-Idade , Risco , Esquizofrenia/genética , Esquizofrenia/patologia , População Branca , Família de Proteínas da Síndrome de Wiskott-Aldrich/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA